Potential Novel Therapeutic Target to Improve Graft Survival: New Insights Into the Role of Checkpoint Molecules in Heart Transplant Rejection

Correspondence to: Bettina Heidecker, MD, Head of Heart Failure and Cardiomyopathies, Charité, Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany. Email

E-mail Address: [email protected]

https://orcid.org/0000-0002-3811-7920